Publication | Open Access

Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease

Cell TherapyTransplantationMarrow TransplantationBone Marrow FailureGeneticsStem Cell TransplantationHematologyStem Cell ResearchEarly Lineage-specific ChimerismMyeloid DiseaseCell BiologyMedicineCell TransplantationClinical OutcomeMyeloid Neoplasia